1-9 of 9
James L. Murray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype

Richard C. Wu, Shujuan Liu, Jessica A. Chacon, Sheng Wu, Yufeng Li, Pariya Sukhumalchandra, James L. Murray, Jeffrey J. Molldrem, Patrick Hwu, Hanspeter Pircher, Gregory Lizée, Laszlo G. Radvanyi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2465–2477.
https://doi.org/10.1158/1078-0432.CCR-11-2034
Published: 30 April 2012
View article titled, Detection and Characterization of a Novel Subset of CD8<sup>+</sup>CD57<sup>+</sup> T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype
Open the PDF for Detection and Characterization of a Novel Subset of CD8<sup>+</sup>CD57<sup>+</sup> T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype in another window
Includes: Supplementary data
Journal Articles

Clinical Studies of Vaccines Targeting Breast Cancer

Byung K. Ko, Kouichiro Kawano, James L. Murray, Mary L. Disis, Clay L. Efferson, Henry M. Kuerer, George E. Peoples, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3222–3234.
Published: 05 September 2003
View article titled, Clinical Studies of Vaccines Targeting Breast Cancer
Open the PDF for Clinical Studies of Vaccines Targeting Breast Cancer in another window
Journal Articles

A Phase I Study of Docetaxel Plus Cyclophosphamide in Solid Tumors followed by a Phase II Study as First-Line Therapy in Metastatic Breast Cancer

Jonathan C. Trent, Vicente Valero, Daniel J. Booser, Laura T. Esparza-Guerra, Nuhad Ibrahim, Zia Rahman, Laurent Vernillet, Shreyaskumar Patel, Cynthia L. David, James L. Murray, Massimo Cristofanilli, Gabriel N. Hortobagyi
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2426–2434.
Published: 01 July 2003
View article titled, A Phase I Study of Docetaxel Plus Cyclophosphamide in Solid Tumors followed by a Phase II Study as First-Line Therapy in Metastatic Breast Cancer
Open the PDF for A Phase I Study of Docetaxel Plus Cyclophosphamide in Solid Tumors followed by a Phase II Study as First-Line Therapy in Metastatic Breast Cancer in another window
Journal Articles

Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer

James L. Murray, Michael E. Gillogly, Donna Przepiorka, Hannah Brewer, Nuhad K. Ibrahim, Daniel J. Booser, Gabriel N. Hortobagyi, Andrzej P. Kudelka, Kenneth H. Grabstein, Martin A. Cheever, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3407–3418.
Published: 01 November 2002
View article titled, Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer
Open the PDF for Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer in another window
Journal Articles

A Detailed Evaluation of Cardiac Toxicity: A Phase II Study of Doxorubicin and One- or Three-Hour-Infusion Paclitaxel in Patients with Metastatic Breast Cancer

Sharon H. Giordano, Daniel J. Booser, James L. Murray, Nuhad K. Ibrahim, Zia U. Rahman, Vicente Valero, Richard L. Theriault, Marguerite F. Rosales, Edgardo Rivera, Debbie Frye, Michael Ewer, Nelson G. Ordonez, Aman U. Buzdar, Gabriel N. Hortobagyi
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3360–3368.
Published: 01 November 2002
View article titled, A Detailed Evaluation of Cardiac Toxicity: <subtitle>A Phase II Study of Doxorubicin and One- or Three-Hour-Infusion Paclitaxel in Patients with Metastatic Breast Cancer</subtitle>
Open the PDF for A Detailed Evaluation of Cardiac Toxicity: <subtitle>A Phase II Study of Doxorubicin and One- or Three-Hour-Infusion Paclitaxel in Patients with Metastatic Breast Cancer</subtitle> in another window
Journal Articles

Phase I Trial of Intratumoral Liposome E1A Gene Therapy in Patients with Recurrent Breast and Head and Neck Cancer

George H. Yoo, Mien-Chie Hung, Gabriel Lopez-Berestein, Susan LaFollette, John F. Ensley, Mary Carey, Eric Batson, Thomas C. Reynolds, James L. Murray
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1237–1245.
Published: 01 May 2001
View article titled, Phase I Trial of Intratumoral Liposome E1A Gene Therapy in Patients with Recurrent Breast and Head and Neck Cancer
Open the PDF for Phase I Trial of Intratumoral Liposome E1A Gene Therapy in Patients with Recurrent Breast and Head and Neck Cancer in another window
Journal Articles

Peptide Priming of Cytolytic Activity to HER-2 Epitope 369–377 in Healthy Individuals

Brett W. Anderson, George E. Peoples, James L. Murray, Michael A. Gillogly, David M. Gershenson, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4192–4200.
Published: 01 November 2000
View article titled, Peptide Priming of Cytolytic Activity to HER-2 Epitope 369–377 in Healthy Individuals
Open the PDF for Peptide Priming of Cytolytic Activity to HER-2 Epitope 369–377 in Healthy Individuals in another window
Journal Articles

Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers

George E. Peoples, Brett W. Anderson, Tom V. Lee, James L. Murray, Andrezj P. Kudelka, J. Taylor Wharton, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4214–4223.
Published: 01 December 1999
View article titled, Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers
Open the PDF for Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers in another window
Journal Articles

Phase I Study of 90Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity

Michael G. Rosenblum, Claire F. Verschraegen, James L. Murray, Andrzej P. Kudelka, Jacalyn Gano, Lawrence Cheung, John J. Kavanagh
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (5): 953–961.
Published: 01 May 1999
View article titled, Phase I Study of <sup>90</sup>Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity
Open the PDF for Phase I Study of <sup>90</sup>Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity in another window